What are the recommended treatments for xerostomia (dry mouth)?

Treatment of Dry Mouth (Xerostomia)

Treatment should be guided by objective measurement of salivary gland function, not patient symptoms alone, with therapy stratified into non-pharmacological stimulation for mild dysfunction, pharmacological stimulation with muscarinic agonists for moderate dysfunction, and saliva substitution for severe/absent salivary output. 1

Initial Assessment

Before initiating any treatment, measure whole salivary flow rates to objectively assess glandular function, as subjective dry mouth symptoms often do not correlate with actual salivary output due to environmental and psychological factors 1. Rule out unrelated conditions including candidiasis and burning mouth syndrome before attributing symptoms to xerostomia 1.

Treatment Algorithm Based on Salivary Function

Mild Glandular Dysfunction (Residual Salivary Capacity Present)

Start with non-pharmacological salivary stimulation as first-line therapy: 1

• Gustatory stimulants: Sugar-free acidic candies, lozenges containing xylitol 1
• Mechanical stimulants: Sugar-free chewing gum 1
• Ideal preparations should have neutral pH and contain fluoride plus electrolytes to mimic natural saliva 1

The evidence shows these interventions relieve symptoms to some degree, though no single non-pharmacological approach has proven superior to others 1, 2. Chewing gum increases saliva production in those with residual secretory capacity and may be preferred by patients 2.

Moderate Glandular Dysfunction

Offer a trial of muscarinic agonists (cholinergic sialogogues): 1

• Pilocarpine (licensed worldwide) or cevimeline (limited availability) 1
• Pilocarpine can be used as-needed rather than fixed-dose, which reduces side effects and improves tolerability while maintaining efficacy (mean XI score reduction of 49.77% with as-needed dosing) 3
• Cevimeline demonstrates a better tolerance profile than pilocarpine in comparative studies 1
• These agents improve subjective dry mouth symptoms and salivary flow rates in randomized trials, though adverse events are common 1

Important caveat: Also consider muscarinic agonists for patients with mild dysfunction who fail or refuse non-pharmacological measures 1.

Severe Dysfunction (No Salivary Output)

Use saliva substitutes as the primary approach: 1

• Oxygenated glycerol triester (OGT) spray shows the strongest evidence, providing approximately 2 points improvement on a 10-point visual analog scale compared to electrolyte sprays 2
• Available formulations include oral sprays, gels, rinses, and ointments 1
• Products containing sodium hyaluronate demonstrate significant improvement in both subjective symptoms and objective measures (ROAG scores) 4
• 1% malic acid spray and 1.33% betaine-based mouthwash both significantly improve dry mouth sensation and quality of life, with comparable efficacy 5
• Products should contain lubricants with polymeric bases or viscosity agents (methylcellulose, hyaluronate) 1

Additional Therapeutic Considerations

For Radiation-Induced Xerostomia

• Tissue-sparing radiation modalities (IMRT) should be used when possible to prevent salivary gland damage 6
• Bethanechol and acupuncture may be offered during radiation therapy as risk-reducing interventions 6
• Post-radiation: oral pilocarpine, oral cevimeline, acupuncture, or transcutaneous electrostimulation 6

Adjunctive Measures

• Maintain adequate hydration and use salivary stimulation techniques 7
• Practice good oral hygiene to prevent dental caries, periodontal disease, and oral infections that commonly complicate chronic xerostomia 8
• Review medications for anticholinergic effects, as polypharmacy is the most common cause of dry mouth in older adults 8

Common Pitfalls

Do not rely on patient-reported symptoms alone to guide treatment selection—objective salivary flow measurement is essential for appropriate therapy stratification 1. The mismatch between subjective complaints and objective function leads to inappropriate treatment choices.

Muscarinic agonists have significant adverse event profiles (cholinergic side effects including sweating, nausea, urinary frequency), so reserve them for moderate dysfunction or failed conservative therapy 1. As-needed dosing reduces side effects compared to fixed schedules 3.

Not all topical therapies are equal—while many products exist, only OGT spray has robust evidence showing superiority over placebo with clinically meaningful effect sizes 2.